European journal of internal medicine
-
Eur. J. Intern. Med. · Nov 2024
Meta AnalysisDoor-to-antibiotic time and mortality in patients with sepsis: Systematic review and meta-analysis.
To evaluate whether the timing of initial antibiotic administration in patients with sepsis in hospital affects mortality. ⋯ Our findings show an improvement in mortality in sepsis patients with early administration of antibiotics at <3 and <6 hrs. Thus, these results suggest that antibiotics should be administered within 3 hrs of sepsis recognition or ED arrival regardless of the presence or absence of shock.
-
Eur. J. Intern. Med. · Nov 2024
Multicenter StudyAssociations of cannabis use and body mass index-The Coronary Artery Risk Development in Young Adults (CARDIA) study.
With increasing use of cannabis, we need to know if cannabis use and Body Mass Index (BMI) are associated. ⋯ Current cannabis use was associated with lower BMI, but cumulative cannabis use and cessation were not. This suggests that recreational cannabis use may not lead to clinically relevant changes in BMI and that the association between current cannabis use and lower BMI is likely due to residual confounding.
-
Eur. J. Intern. Med. · Nov 2024
ReviewPulmonary hypertension associated to left heart disease: Phenotypes and treatment.
Pulmonary hypertension associated to left heart disease (PH-LHD) refers to a clinical and haemodynamic condition of pulmonary hypertension associated with a heterogeneous group of diseases affecting any of the compartments that form the left ventricle and left atrium. PH-LHD is the most common cause of PH, accounting for 65-80 % of diagnoses. Based on the haemodynamic phase of the disease, PH-LDH is classified into three subgroups: postcapillary PH, isolated postcapillary PH and combined pre-postcapillary PH (CpcPH). ⋯ In this manuscript we provide a state of the art of the available clinical trials investigating the safety and efficacy of PAH-specific drugs, as well as drugs active in patients with heart failure and PH-LHD. We also discuss the different phenotypes of PH-LHD, as well as molecular targets and signaling pathways potentially involved in the pathophysiology of the disease. Finally we will mention some new emerging therapies that can be used to treat this form of PH.